Back

Protein Interactions: Detection and Identification

Request Number N283903
Need details
Description

Thermo Fisher Scientific is seeking partners and opportunities to develop and commercialize novel technologies to detect protein:protein, protein:nucleic acid, and/or

protein:small molecule interactions. 

 

Background

Protein interactions are important in drug discovery, studying cell signaling mechanisms, and understanding protein function and structure. Often more than one approach or methodology is necessary to validate an interaction.

 

Key Success Criteria

The successful technology should meet some or all of the following criteria:

  • Detect transient interactions
  • Capable of detecting multiprotein complexes
  • Amenable to use in vitro and in cultured cells
  • Able to quantify the interaction (frequency and/or affinity)
  • Identify subcellular location of interaction
  • Detect posttranslational modifications
  • Reproducible
  • Minimizes operator hands-on time

 

Possible Approaches
  • Stabilization of protein complexes prior to isolation
  • Detection of endogenous protein complexes
  • Over-expression systems employing detectors, unique tags, or affinity handles
  • Label-free detection

 

Approaches not of interest
  • Yeast-2-hybrid and yeast-1-hybrid
  • Immunoprecipitation and co-immunoprecipitation
  • Phage display
  • Gel shift assay

 

Preferred Collaboration types
  • Joint Development
  • Technology Licensing
  • Technology Acquisition
  • To Be Negotiated
Items to be submitted
We are looking for concise, nonconfidential proposals. The proposal should:
  • Describe the technical approach
  • Include a description of the responding organization or team and their experience
We recommend:
  • Including a concise abstract summarizing your submission
  • Attaching your proposal
  • Attaching any additional documents

Please note that only nonconfidential information can be accepted. By submitting a response, you confirm that the response does not contain any confidential information.

 

Point of Contact
Jonathan Jakischa
Area of Interest
  • Medical Products & Services
  • Other
  • Pharmaceuticals
  • Pharmaceutical R & D
  • Other
Organization
Thermo Fisher Scientific
Due Date
May 11, 2018
Attachments
This page does not have file attachments.
This page does not have file attachments.
Comments